Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin and Ezetimibe in High-Risk Hypercholesterolemia
NCT00653445Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2004
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of rosuvastatin, ezetimibe in hypercholesterolemia, sponsored by AstraZeneca. Started Jun 2004; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00653445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00653445.